Axa
OPTR

Axa’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Axa’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-512,816
Closed -$6.46M – 1479
2013
Q3 		$6.46M Buy
512,816
+48,499
+10% +$643K 0.03% 464
2013
Q2 		$6.72M Buy
+464,317
New +$6.76M 0.04% 430

Axa's OPTR Position: Q4 2013 in Review

Axa sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 512,816 shares — an estimated $6.46M sold.

Axa first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $6.72M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Axa reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Axa sold 512,816 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $6.46M.
  • Axa first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Axa's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $6.72M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Axa's 13F filing for Q4 2013, filed 13 Feb 2014.